Hard to heal wounds that are difficult to heal is a serious and costly complication of underlying diseases such as diabetes, venous insufficiency or injuries to the skin such as pressure ulcers.

Patients suffering from these wounds often experience pain, a bad smell, decreased mobility and other problems which seriously affecting the quality of life.

The number of patients suffering from chronic, hard to heal wounds is increasing due to the demographic trends and increased incidence of underlying diseases. It has been estimated that 1 to 2 percent of the population will experience a chronic wound during their lifetime¹.

The number of adults with diabetes in the world increased from 151 million in 1980 to 425 million patients in 2017 with a clear trend pointing towards further growth in the coming decades².

The global incidence of diabetic foot ulcers has been estimated to be 6.3 percent. From 19 to 34 percent of persons with diabetes are likely to be affected by diabetic foot ulcers during their lifetime³. Furthermore, approximately 50 percent of the ulcers will become infected requiring hospitalization and it has been reported that 20 percent of the lower extremity infections will result in amputation⁴. Mortality rates are very high after amputation with up to 70 percent of people dying within 5 years⁵.

Our overall goal is to provide a gentle and effective debridement method that result in improved care for healthcare professionals reducing the suffering for patients and the overall cost for the society in treating complicated wounds.